Information for
investors.
Explore the offering information and documents published by Ibex Biosciences.
Review the
materials.
Ibex Biosciences is fundraising through an offering under Rule 506(c) of Regulation D.
Only accredited investors may purchase securities in a Rule 506(c) offering. Ibex must take reasonable steps to verify each purchaser’s accredited investor status before a sale. The securities are offered in reliance on an exemption from registration under the Securities Act of 1933 and are restricted securities, subject to limits on resale.
An investment in an early-stage biotechnology company involves substantial risk, including possible loss of the entire investment, and may be illiquid. The SEC has not approved this offering or passed on its merits. Any investment decision should be based on the current offering documents and subscription materials, which contain the terms and risk disclosures. Consult your own legal, tax, and financial advisers. Learn about Rule 506(c) at the SEC ↗
The investor instructions describe how to review the portal materials, complete subscription documents, provide accredited-investor verification, and fund an investment.
Open investment portal